Domestic medical AI companies, including Phantomics and Coreline Soft, are heating up the market competition with the release of new products, raising expectations for increased sales. According to the industry on the 21st, Korean medical imaging diagnosis AI companies such as Phantomics, Coreline Soft, and Deep Bio have recently released new products, including AI software for automatic analysis of cardiac magnetic resonance imaging (MRI), a service-type software solution for diagnosing lung diseases, and an AI-assisted solution for diagnosing prostate cancer. Phantomics recently received simultaneous sales approval from the Ministry of Food and Drug Safety for its "Myomics-T1" and "Myomics-T2" AI diagnostic support software for automatic analysis of cardiac MRI.